Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Making a diagnosis in severe cutaneous drug hypersensitivity reactions.

Ardern-Jones MR, Mockenhaupt M.

Curr Opin Allergy Clin Immunol. 2019 Aug;19(4):283-293. doi: 10.1097/ACI.0000000000000546.

PMID:
31247634
2.

Adalimumab Biosimilars in Europe: An Overview of the Clinical Evidence.

Bellinvia S, Cummings JRF, Ardern-Jones MR, Edwards CJ.

BioDrugs. 2019 Jun;33(3):241-253. doi: 10.1007/s40259-019-00355-4. Review.

PMID:
31111422
3.

EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity.

Brockow K, Ardern-Jones MR, Mockenhaupt M, Aberer W, Barbaud A, Caubet JC, Spiewak R, Torres MJ, Mortz CG.

Allergy. 2019 Jan;74(1):14-27. doi: 10.1111/all.13562. Epub 2018 Dec 5.

PMID:
30028512
4.

The Royal College of Ophthalmologists recommendations on screening for hydroxychloroquine and chloroquine users in the United Kingdom: executive summary.

Yusuf IH, Foot B, Galloway J, Ardern-Jones MR, Watson SL, Yelf C, Burdon MA, Bishop PN, Lotery AJ.

Eye (Lond). 2018 Jul;32(7):1168-1173. doi: 10.1038/s41433-018-0136-x. Epub 2018 Jun 11. Review. No abstract available.

5.

Joint recommendations for retinal screening in long-term users of hydroxychloroquine and chloroquine in the United Kingdom, 2018.

Yusuf IH, Lotery AJ, Ardern-Jones MR.

Br J Dermatol. 2018 Oct;179(4):995-996. doi: 10.1111/bjd.16782. Epub 2018 Sep 5. No abstract available.

PMID:
29770429
6.

Microwave therapy for cutaneous human papilloma virus infection.

Bristow I, Lim WC, Lee A, Holbrook D, Savelyeva N, Thomson P, Webb C, Polak M, Ardern-Jones MR.

Eur J Dermatol. 2017 Oct 1;27(5):511-518. doi: 10.1684/ejd.2017.3086.

PMID:
29084638
7.

The Successful Use of a Novel Microwave Device in the Treatment of a Plantar Wart.

Bristow IR, Webb C, Ardern-Jones MR.

Case Rep Dermatol. 2017 Jul 27;9(2):102-107. doi: 10.1159/000477377. eCollection 2017 May-Aug.

8.

When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council.

Simpson EL, Bruin-Weller M, Flohr C, Ardern-Jones MR, Barbarot S, Deleuran M, Bieber T, Vestergaard C, Brown SJ, Cork MJ, Drucker AM, Eichenfield LF, Foelster-Holst R, Guttman-Yassky E, Nosbaum A, Reynolds NJ, Silverberg JI, Schmitt J, Seyger MMB, Spuls PI, Stalder JF, Su JC, Takaoka R, Traidl-Hoffmann C, Thyssen JP, van der Schaft J, Wollenberg A, Irvine AD, Paller AS.

J Am Acad Dermatol. 2017 Oct;77(4):623-633. doi: 10.1016/j.jaad.2017.06.042. Epub 2017 Aug 10.

9.

Petri Net computational modelling of Langerhans cell Interferon Regulatory Factor Network predicts their role in T cell activation.

Polak ME, Ung CY, Masapust J, Freeman TC, Ardern-Jones MR.

Sci Rep. 2017 Apr 6;7(1):668. doi: 10.1038/s41598-017-00651-5.

10.

Myaesthenia gravis exacerbation caused by axillary injection of botulinum toxin A for treatment of hyperhidrosis.

El-Heis S, Burke G, Gibb W, Ardern-Jones MR.

Clin Exp Dermatol. 2017 Apr;42(3):357-359. doi: 10.1111/ced.13036. Epub 2017 Jan 23. No abstract available.

PMID:
28111784
11.

Characterisation of atopic dermatitis (AD) endotypes and novel treatment targets: towards a molecular classification.

Ardern-Jones MR.

Exp Dermatol. 2018 Apr;27(4):433-434. doi: 10.1111/exd.13152. Epub 2016 Dec 27. No abstract available.

PMID:
27488915
12.

U.K. guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016.

Creamer D, Walsh SA, Dziewulski P, Exton LS, Lee HY, Dart JK, Setterfield J, Bunker CB, Ardern-Jones MR, Watson KM, Wong GA, Philippidou M, Vercueil A, Martin RV, Williams G, Shah M, Brown D, Williams P, Mohd Mustapa MF, Smith CH.

Br J Dermatol. 2016 Jun;174(6):1194-227. doi: 10.1111/bjd.14530. No abstract available.

PMID:
27317286
13.

UK guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016.

Creamer D, Walsh SA, Dziewulski P, Exton LS, Lee HY, Dart JKG, Setterfield J, Bunker CB, Ardern-Jones MR, Watson KMT, Wong GAE, Philippidou M, Vercueil A, Martin RV, Williams G, Shah M, Brown D, Williams P, Mohd Mustapa MF, Smith CH.

J Plast Reconstr Aesthet Surg. 2016 Jun;69(6):e119-e153. doi: 10.1016/j.bjps.2016.01.034.

PMID:
27287213
14.

In vitro rapid diagnostic tests for severe drug hypersensitivity reactions in children.

Haw WY, Polak ME, McGuire C, Erlewyn-Lajeunesse M, Ardern-Jones MR.

Ann Allergy Asthma Immunol. 2016 Jul;117(1):61-6. doi: 10.1016/j.anai.2016.04.017. Epub 2016 May 21.

PMID:
27221062
15.

UK guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016 (print summary - Full guidelines available at http://dx.doi.org/10.1016/j.bjps.2016.01.034).

Creamer D, Walsh SA, Dziewulski P, Exton LS, Lee HY, Dart JKG, Setterfield J, Bunker CB, Ardern-Jones MR, Watson KMT, Wong GAE, Philippidou M, Vercueil A, Martin RV, Williams G, Shah M, Brown D, Williams P, Mohd Mustapa MF, Smith CH.

J Plast Reconstr Aesthet Surg. 2016 Jun;69(6):736-741. doi: 10.1016/j.bjps.2016.04.018. Epub 2016 May 7. No abstract available.

PMID:
27216885
16.

Staphylococcus aureus and chronic folliculocentric pustuloses of the scalp - cause or association?

Lee AH, Cho SY, Yam TS, Harris K, Ardern-Jones MR.

Br J Dermatol. 2016 Aug;175(2):410-3. doi: 10.1111/bjd.14518. Epub 2016 May 29. No abstract available.

PMID:
26949158
17.

Association between Micronutrient Levels and Chronic Spontaneous Urticaria.

Wu CH, Eren E, Ardern-Jones MR, Venter C.

Biomed Res Int. 2015;2015:926167. doi: 10.1155/2015/926167. Epub 2015 Oct 22.

18.

Retrospective case note review of chronic spontaneous urticaria outcomes and adverse effects in patients treated with omalizumab or ciclosporin in UK secondary care.

Savic S, Marsland A, McKay D, Ardern-Jones MR, Leslie T, Somenzi O, Baldock L, Grattan C.

Allergy Asthma Clin Immunol. 2015 Jul 21;11(1):21. doi: 10.1186/s13223-015-0088-7. eCollection 2015.

19.

An Observational Study of the Diagnosis and Management of Chronic Urticaria in the UK.

Wu CH, Ardern-Jones MR, Eren E, Venter C.

Int Arch Allergy Immunol. 2015;167(1):1-8. doi: 10.1159/000430442. Epub 2015 Jun 5.

20.

Conformation of the human immunoglobulin G2 hinge imparts superagonistic properties to immunostimulatory anticancer antibodies.

White AL, Chan HT, French RR, Willoughby J, Mockridge CI, Roghanian A, Penfold CA, Booth SG, Dodhy A, Polak ME, Potter EA, Ardern-Jones MR, Verbeek JS, Johnson PW, Al-Shamkhani A, Cragg MS, Beers SA, Glennie MJ.

Cancer Cell. 2015 Jan 12;27(1):138-48. doi: 10.1016/j.ccell.2014.11.001. Epub 2014 Dec 11.

21.

Interactions of skin with gold nanoparticles of different surface charge, shape, and functionality.

Fernandes R, Smyth NR, Muskens OL, Nitti S, Heuer-Jungemann A, Ardern-Jones MR, Kanaras AG.

Small. 2015 Feb 11;11(6):713-21. doi: 10.1002/smll.201401913. Epub 2014 Oct 7.

PMID:
25288531
22.

Biomarkers in atopic dermatitis: it is time to stratify.

Ardern-Jones MR, Bieber T.

Br J Dermatol. 2014 Aug;171(2):207-8. doi: 10.1111/bjd.13210. No abstract available.

PMID:
25135047
23.

Primary cutaneous nodular amyloidosis associated with psoriasis.

Ung CY, Carr NJ, Ardern-Jones MR.

Clin Exp Dermatol. 2014 Jul;39(5):608-11. doi: 10.1111/ced.12347. Epub 2014 May 30.

PMID:
24888341
24.

Distinct molecular signature of human skin Langerhans cells denotes critical differences in cutaneous dendritic cell immune regulation.

Polak ME, Thirdborough SM, Ung CY, Elliott T, Healy E, Freeman TC, Ardern-Jones MR.

J Invest Dermatol. 2014 Mar;134(3):695-703. doi: 10.1038/jid.2013.375. Epub 2013 Sep 4.

25.

Sensitization via healthy skin programs Th2 responses in individuals with atopic dermatitis.

Newell L, Polak ME, Perera J, Owen C, Boyd P, Pickard C, Howarth PH, Healy E, Holloway JW, Friedmann PS, Ardern-Jones MR.

J Invest Dermatol. 2013 Oct;133(10):2372-2380. doi: 10.1038/jid.2013.148. Epub 2013 Mar 25.

26.

Atypical erythema multiforme is a prognostic indicator of severe hepatic dysfunction in Dress (Drug Reaction with Eosinophilia and Systemic Symptoms).

Ardern-Jones MR.

Br J Dermatol. 2013 Feb;168(2):234-5. doi: 10.1111/bjd.12191. No abstract available.

PMID:
23362966
27.

In vitro diagnostic assays are effective during the acute phase of delayed-type drug hypersensitivity reactions.

Polak ME, Belgi G, McGuire C, Pickard C, Healy E, Friedmann PS, Ardern-Jones MR.

Br J Dermatol. 2013 Mar;168(3):539-49. doi: 10.1111/bjd.12109. Epub 2013 Jan 31.

PMID:
23106791
28.

CD70-CD27 interaction augments CD8+ T-cell activation by human epidermal Langerhans cells.

Polak ME, Newell L, Taraban VY, Pickard C, Healy E, Friedmann PS, Al-Shamkhani A, Ardern-Jones MR.

J Invest Dermatol. 2012 Jun;132(6):1636-44. doi: 10.1038/jid.2012.26. Epub 2012 Mar 1.

29.

Skin manifestations of drug allergy.

Ardern-Jones MR, Friedmann PS.

Br J Clin Pharmacol. 2011 May;71(5):672-83. doi: 10.1111/j.1365-2125.2010.03703.x. Review.

30.

Identification of an immunodominant region of Fel d 1 and characterization of constituent epitopes.

Bateman EA, Ardern-Jones MR, Ogg GS.

Clin Exp Allergy. 2008 Nov;38(11):1760-8. doi: 10.1111/j.1365-2222.2008.03098.x.

PMID:
19489916
31.

Anti-lymphocyte function associated antigen-1 inhibits T-helper 2 function of human allergen-specific CD4+ T cells.

Ardern-Jones MR, Black AP, Ogg GS.

Br J Dermatol. 2008 Mar;158(3):456-62. doi: 10.1111/j.1365-2133.2007.08393.x. Epub 2008 Jan 17.

PMID:
18205875
32.

Human keratinocyte induction of rapid effector function in antigen-specific memory CD4+ and CD8+ T cells.

Black AP, Ardern-Jones MR, Kasprowicz V, Bowness P, Jones L, Bailey AS, Ogg GS.

Eur J Immunol. 2007 Jun;37(6):1485-93.

33.

Bacterial superantigen facilitates epithelial presentation of allergen to T helper 2 cells.

Ardern-Jones MR, Black AP, Bateman EA, Ogg GS.

Proc Natl Acad Sci U S A. 2007 Mar 27;104(13):5557-62. Epub 2007 Mar 19.

34.

Persistent central memory phenotype of circulating Fel d 1 peptide/DRB1*0101 tetramer-binding CD4+ T cells.

Bateman EA, Ardern-Jones MR, Ogg GS.

J Allergy Clin Immunol. 2006 Dec;118(6):1350-6. Epub 2006 Sep 12.

PMID:
17137868
35.

Blistering eruption on an elderly woman's leg--quiz case.

Ardern-Jones MR, James MP.

Arch Dermatol. 2004 Apr;140(4):479-84. No abstract available.

PMID:
15096379
36.

Widespread morphoea following radiotherapy for carcinoma of the breast.

Ardern-Jones MR, Black MM.

Clin Exp Dermatol. 2003 Mar;28(2):160-2.

PMID:
12653704
37.

Oral and topical corticosteroids in bullous pemphigoid.

Ardern-Jones MR, Venning VA, Wojnarowska F.

N Engl J Med. 2002 Jul 11;347(2):143-5; author reply 143-5. No abstract available.

PMID:
12110747
38.

Widespread bullous eruption due to multiple bed bug bites.

Fletcher CL, Ardern-Jones MR, Hay RJ.

Clin Exp Dermatol. 2002 Jan;27(1):74-5. No abstract available.

PMID:
11952681

Supplemental Content

Loading ...
Support Center